z-logo
Premium
pVHL ‐mediated degradation of HIF ‐2α regulates estrogen receptor α expression in normoxic breast cancer cells
Author(s) -
Higashimura Yasuki,
Kitakaze Tomoya,
Harada Naoki,
Inui Hiroshi,
Nakano Yoshihisa,
Yamaji Ryoichi
Publication year - 2016
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1002/1873-3468.12265
Subject(s) - estrogen receptor , gene knockdown , transcription factor , chemistry , microbiology and biotechnology , hypoxia inducible factors , estrogen receptor alpha , receptor , regulator , cancer research , estrogen , biology , breast cancer , gene , endocrinology , cancer , biochemistry , genetics
Estrogen receptor α ( ER α) functions as a transcription factor for genes involved in estrogen‐dependent development of breast cancer cells. We demonstrate here that knockdown of hypoxia‐inducible factor ( HIF )‐2α, but not of HIF ‐1α, increases endogenous ER α protein expression in normoxia and hypoxia. The von Hippel–Lindau protein ( pVHL )‐dependent degradation of HIF ‐2α participates in the regulation of ER α expression. Additionally, HIF ‐2α forms a protein complex with ER α, and amino acids 396–823 of HIF ‐2α physically interact with the ligand‐binding domain of ER α. These results indicate that HIF ‐2α functions as a negative regulator of ER α expression in breast cancer, especially in normoxia.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom